USE OF CORTICOSTEROIDS IN A NORWEGIAN COHORT OF PATIENTS WITH IGA NEPHROPATHY AND RAPID PROGRESSION TO END-STAGE RENAL DISEASE

被引：0
|
作者：
Haaskjold, Yngvar Lunde [1 ,2 ]
Rivedal, Mariell [2 ]
Lura, Njal Gjaerde [3 ]
Bjorneklett, Rune [2 ,4 ]
Knoop, Thomas [1 ,2 ]
机构：
[1] Haukeland Univ Hosp Hlth Bergen, Med, Bergen, Norway
[2] Univ Bergen, Med Clin, Bergen, Norway
[3] Haukeland Univ Hosp Hlth Bergen, Radiol, Bergen, Norway
[4] Haukeland Univ Hosp Hlth Bergen, Emergency Care Clin, Bergen, Norway
来源：
NEPHROLOGY DIALYSIS TRANSPLANTATION | 2022年 / 37卷
关键词：
D O I：
暂无
中图分类号：
R3 [基础医学]; R4 [临床医学];
学科分类号：
1001 ; 1002 ; 100602 ;
摘要：
MO268
引用
收藏
页码：I192 / I192
页数：1
相关论文
共 50 条
  • [1] Impact of selectin gene polymorphisms on rapid progression to end-stage renal disease in patients with IgA nephropathy
    Watanabe, Yusuke
    Inoue, Tsutomu
    Okada, Hirokazu
    Kotaki, Shuhei
    Kanno, Yoshihiko
    Kikuta, Tomohiro
    Suzuki, Hiromichi
    INTERNAL MEDICINE, 2006, 45 (16) : 947 - 951
  • [2] Use of corticosteroids in Norwegian patients with immunoglobulin a nephropathy progressing to end-stage kidney disease: a retrospective cohort study
    Rivedal, Mariell
    Haaskjold, Yngvar Lunde
    Eikrem, Oystein
    Bjorneklett, Rune
    Marti, Hans Peter
    Knoop, Thomas
    BMC NEPHROLOGY, 2024, 25 (01) : 42
  • [3] Use of corticosteroids in Norwegian patients with immunoglobulin a nephropathy progressing to end-stage kidney disease: a retrospective cohort study
    Mariell Rivedal
    Yngvar Lunde Haaskjold
    Øystein Eikrem
    Rune Bjørneklett
    Hans Peter Marti
    Thomas Knoop
    BMC Nephrology, 25
  • [4] IGA NEPHROPATHY: FACTORS THAT INFLUENCE RENAL SURVIVAL AND PROGRESSION TO END-STAGE RENAL DISEASE
    Correia, Ana Luisa
    Pimenta, Ana Carolina
    Pinto, Helena
    Marques, Maria Guedes
    Alves, Rui
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2022, 37 : I140 - I141
  • [5] IgA Nephropathy Factors that Predict and Accelerate Progression to End-Stage Renal Disease
    Huang, Lan
    Guo, Feng-Ling
    Zhou, Jin
    Zhao, Ya-Juan
    CELL BIOCHEMISTRY AND BIOPHYSICS, 2014, 68 (03) : 443 - 447
  • [6] IgA Nephropathy Factors that Predict and Accelerate Progression to End-Stage Renal Disease
    Lan Huang
    Feng-Ling Guo
    Jin Zhou
    Ya-Juan Zhao
    Cell Biochemistry and Biophysics, 2014, 68 : 443 - 447
  • [7] IgA nephropathy: What patients are at risk of progression to end-stage renal disease and how should they be treated?
    Praga, Manuel
    Caravaca, Fernando
    Yuste, Claudia
    Cavero, Teresa
    Hernandez, Eduardo
    Morales, Enrique
    Merida, Eva
    Moreno, Juan Antonio
    Sevillano, Angel
    Gutierrez, Eduardo
    NEFROLOGIA, 2018, 38 (04): : 347 - 352
  • [8] RISK FACTORS FOR END-STAGE RENAL DISEASE IN IGA NEPHROPATHY
    Sahar, Bouassida
    Khadhar, Meriam
    Sarra, Hadded
    Jerbi, Mouna
    Hanen, Gaied
    Raja, Aoudia
    Rym, Goucha
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2023, 38 : I1151 - I1151
  • [9] Increased risk of end-stage renal disease in familial IgA nephropathy
    Schena, FP
    Cerullo, G
    Rossini, M
    Lanzilotta, SG
    D'Altri, C
    Manno, C
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2002, 13 (02): : 453 - 460
  • [10] The prognostic role of activation of the complement pathways in the progression of advanced IgA nephropathy to end-stage renal disease
    Wang, Ying
    Jiang, Shimin
    Di, Dingxin
    Zou, Guming
    Gao, Hongmei
    Shang, Shunlai
    Li, Wenge
    BMC NEPHROLOGY, 2024, 25 (01)
12345